Egetis Therapeutics AB (publ)
STO:EGTX

Watchlist Manager

Egetis Therapeutics AB (publ)

STO:EGTX

Watchlist

Dividends

Price: 6.65 SEK 0.91% Market Closed

Market Cap: 2.4B SEK

Have any thoughts about
Egetis Therapeutics AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 6.65 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

EGTX Alert

Egetis Therapeutics AB (publ)

6.65

+0.06 (+0.91%)

52 Week Range	4.1 9.18
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Egetis Therapeutics AB (publ)

What unique competitive advantages
does Egetis Therapeutics AB (publ) hold over its rivals?

What risks and challenges
does Egetis Therapeutics AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Egetis Therapeutics AB (publ).

What unique competitive advantages
does Egetis Therapeutics AB (publ) hold over its rivals?

What risks and challenges
does Egetis Therapeutics AB (publ) face in the near future?

Has there been any significant insider trading activity
in Egetis Therapeutics AB (publ) recently?

Summarize the latest earnings call
of Egetis Therapeutics AB (publ).

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Egetis Therapeutics AB (publ).

Provide P/S
for Egetis Therapeutics AB (publ).

Provide P/E
for Egetis Therapeutics AB (publ).

Provide P/OCF
for Egetis Therapeutics AB (publ).

Provide P/FCFE
for Egetis Therapeutics AB (publ).

Provide P/B
for Egetis Therapeutics AB (publ).

Provide EV/S
for Egetis Therapeutics AB (publ).

Provide EV/GP
for Egetis Therapeutics AB (publ).

Provide EV/EBITDA
for Egetis Therapeutics AB (publ).

Provide EV/EBIT
for Egetis Therapeutics AB (publ).

Provide EV/OCF
for Egetis Therapeutics AB (publ).

Provide EV/FCFF
for Egetis Therapeutics AB (publ).

Provide EV/IC
for Egetis Therapeutics AB (publ).

Show me price targets
for Egetis Therapeutics AB (publ) made by professional analysts.

What are the Revenue projections
for Egetis Therapeutics AB (publ)?

How accurate were the past Revenue estimates
for Egetis Therapeutics AB (publ)?

What are the Net Income projections
for Egetis Therapeutics AB (publ)?

How accurate were the past Net Income estimates
for Egetis Therapeutics AB (publ)?

What are the EPS projections
for Egetis Therapeutics AB (publ)?

How accurate were the past EPS estimates
for Egetis Therapeutics AB (publ)?

What are the EBIT projections
for Egetis Therapeutics AB (publ)?

How accurate were the past EBIT estimates
for Egetis Therapeutics AB (publ)?

Compare the revenue forecasts
for Egetis Therapeutics AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Egetis Therapeutics AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Egetis Therapeutics AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Egetis Therapeutics AB (publ) compared to its peers.

Compare the P/E ratios
of Egetis Therapeutics AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Egetis Therapeutics AB (publ) with its peers.

Analyze the financial leverage
of Egetis Therapeutics AB (publ) compared to its main competitors.

Show all profitability ratios
for Egetis Therapeutics AB (publ).

Provide ROE
for Egetis Therapeutics AB (publ).

Provide ROA
for Egetis Therapeutics AB (publ).

Provide ROIC
for Egetis Therapeutics AB (publ).

Provide ROCE
for Egetis Therapeutics AB (publ).

Provide Gross Margin
for Egetis Therapeutics AB (publ).

Provide Operating Margin
for Egetis Therapeutics AB (publ).

Provide Net Margin
for Egetis Therapeutics AB (publ).

Provide FCF Margin
for Egetis Therapeutics AB (publ).

Show all solvency ratios
for Egetis Therapeutics AB (publ).

Provide D/E Ratio
for Egetis Therapeutics AB (publ).

Provide D/A Ratio
for Egetis Therapeutics AB (publ).

Provide Interest Coverage Ratio
for Egetis Therapeutics AB (publ).

Provide Altman Z-Score Ratio
for Egetis Therapeutics AB (publ).

Provide Quick Ratio
for Egetis Therapeutics AB (publ).

Provide Current Ratio
for Egetis Therapeutics AB (publ).

Provide Cash Ratio
for Egetis Therapeutics AB (publ).

What is the historical Revenue growth
over the last 5 years for Egetis Therapeutics AB (publ)?

What is the historical Net Income growth
over the last 5 years for Egetis Therapeutics AB (publ)?

What is the current Free Cash Flow
of Egetis Therapeutics AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Egetis Therapeutics AB (publ).

Section:

Dividends

Egetis Therapeutics AB (publ)

does not pay dividends

Shareholder Yield

Current shareholder yield for EGTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield

= Dividend Yield

+ Buyback Yield

+ Debt Paydown Yield

Shareholder Yield

Use Debt Paydown Yield

Dividend Yield

No dividends

Buyback Yield

Lowest

Average

Highest

Debt Paydown Yield

Lowest

Average

Highest

Peers Comparison
Shareholder Yield

Use Debt Paydown Yield

	Company	Total Yield	Dividend Yield	Buyback Yield	Debt Paydown Yield

Buybacks

Buyback Yield
Egetis Therapeutics AB (publ)

Period

10Y

15Y

30Y

Yield Statistics, Past 5 Years

Min

Max

Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

	Company	Buyback Yield	Average Yield (3Y)	Average Yield (5Y)	Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Egetis Therapeutics AB (publ)

Period

10Y

15Y

30Y

Yield Statistics, Past 5 Years

Min

Max

Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

	Company	Debt Paydown Yield	Average Yield (3Y)	Average Yield (5Y)	Average Yield (10Y)

Price Appreciation

EGTX Price
Egetis Therapeutics AB (publ)

1M 1M

+19%

6M 6M

+21%

1Y 1Y

+20%

3Y 3Y

-2%

5Y 5Y

-66%

10Y 10Y

-74%

Annual Price Range

6.65

52w Low

4.1

52w High

9.18

Price Metrics

Average Annual Return	-15.83%
Standard Deviation of Annual Returns	30.33%
Max Drawdown	-85%

Shares Statistics

Market Capitalization	2.4B SEK
Shares Outstanding	359 238 000
Percentage of Shares Shorted	N/A

EGTX Return Decomposition
Main factors of price return

What is price return decomposition?

	Franklin Covey Co NYSE:FC	36.87 USD 1.57%
	Mohawk Industries Inc NYSE:MHK	120.19 USD 0.54%
	Ardmore Shipping Corp NYSE:ASC	12.12 USD 2.02%
	ASGN Inc NYSE:ASGN	84.15 USD 0.71%
	Skyworks Solutions Inc NASDAQ:SWKS	90.35 USD 0.18%
	Weatherford International PLC NASDAQ:WFRD	68.07 USD 1.95%

	Johnson & Johnson NYSE:JNJ	145.85 USD 0.4%
	Bank of America Corp NYSE:BAC	44.38 USD 1.12%
	Mastercard Inc NYSE:MA	535.71 USD 1.28%
	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Abbvie Inc NYSE:ABBV	180 USD 0.9%
	Home Depot Inc NYSE:HD	396.14 USD 0.94%

	Arista Networks Inc NYSE:ANET	114.65 USD 1.38%
	Visa Inc NYSE:V	320.65 USD 1.08%
	Texas Pacific Land Corp NYSE:TPL	1 161.2 USD 1.91%
	KLA Corp NASDAQ:KLAC	650.53 USD 0.39%
	Manhattan Associates Inc NASDAQ:MANH	282.27 USD 1.24%
	Pinduoduo Inc NASDAQ:PDD	99.72 USD -0.86%

	Salesforce Inc NYSE:CRM	344.43 USD 0.45%
	Accenture PLC NYSE:ACN	361.63 USD 0.8%
	ServiceNow Inc NYSE:NOW	1 105.56 USD 1.59%
	EOG Resources Inc NYSE:EOG	120.83 USD 0.82%
	Copart Inc NASDAQ:CPRT	59.11 USD 1.29%
	Applied Materials Inc NASDAQ:AMAT	168.37 USD 0.54%

Egetis Therapeutics AB (publ)
STO:EGTX

Dividends

Shareholder Yield

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Egetis Therapeutics AB (publ)

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Egetis Therapeutics AB (publ)

Peers Comparison
Debt Paydown

Price Appreciation

EGTX Price
Egetis Therapeutics AB (publ)

EGTX Return Decomposition
Main factors of price return

See Also

Company

Help

Tools

Stocks

Egetis Therapeutics AB (publ) STO:EGTX

Dividends

Shareholder Yield

Peers Comparison Shareholder Yield

Buybacks

Buyback Yield Egetis Therapeutics AB (publ)

Peers Comparison Buybacks

Debt Paydown

Debt Paydown Yield Egetis Therapeutics AB (publ)

Peers Comparison Debt Paydown

Price Appreciation

EGTX Price Egetis Therapeutics AB (publ)

EGTX Return Decomposition Main factors of price return

See Also

Company

Help

Tools

Stocks

Egetis Therapeutics AB (publ)
STO:EGTX

Peers Comparison
Shareholder Yield

Buyback Yield
Egetis Therapeutics AB (publ)

Peers Comparison
Buybacks

Debt Paydown Yield
Egetis Therapeutics AB (publ)

Peers Comparison
Debt Paydown

EGTX Price
Egetis Therapeutics AB (publ)

EGTX Return Decomposition
Main factors of price return